Jennifer R Heimall, M.D.

faculty photo
Assistant Professor of Clinical Pediatrics
Department: Pediatrics

Contact information
The Children's Hospital of Philadelphia
34th St. and Civic Center Blvd.
Philadelphia, PA 19104
Office: 215-590-2549
Fax: 215-590-4529
Education:
B.A. (Biology and Exercise Science)
Rutgers Univeristy, 1998.
M.D.
University of Medicine and Dentistry of New Jersey (UMDNJ), 2002.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Arnold, DE, Heimall, JR: A Review of Chronic Granulomatous Disease. Advances in Therapy 34(12): 2543-2557, December 2017.

Heimall, J, Cowan, MJ: Long Term Outcomes of Severe Combined Immune Deficiency: Therapy Implications. Expert Review in Clinical Immunology 13(11): 1029-1040, November 2017.

Bird, JA, Spergel, JM, Jones, SM, Rachid, R, Assa'ad, AH, Wang, J, Leaonard, SA, Laubach, SS, Kim, EH, Vickery, BP, Heimall, J, et.al.: Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial. Journal of Allergy and Clinical Immunology Practice 17: S2213-2198, October 2017.

Heimall, J, Logan, BR, Cowan, MJ, Notarangelo, LD, Griffith, LM, Puck, JM, Kohn, DB, et.al.: Immune Reconstitution and Survival of 100 SCID patients Post Hematopoietic Cell Transplant: A PICTC Natural History Study. Blood October 2017 Notes: 10.1182/blood-2017-05-781849.

Arora, M, Bagi, P, Strongin, A, Heimall, J, Zao, X, Lawrence, MG, Trivedi, A, Henderson, C, Hsu, A, et.al.: Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome. Journal of Clinical Immunology August 2017 Notes: 10.1016/j.jelectrocard.2017.07.016.

Heimall, J, Spergel, JM: New Pathways for Itching in Patients with Atopic Dermatitis? Journal of Allergy and Clinical Immunology 140(2): 393-394, August 2017.

Heimall, J, Buckley, RH, Puck, J, Fleischer, TA, Genera, AR, Haddad, E, Neven, B, Slatter, M, et.al: Recommendation for Screening and Management of Late Effects in Patients with Severe Combined Immune Deficiency after Allogenic Hematopoietic Stem Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Biology Blood Marrow Transplant 23(8): 1229-1240, August 2017.

Barry, JC, Crowley, TB, Jyonouchi, S, Heimall, J, Zackai, EH, Sullivan, KE, McDonald-McGinn, DM: Identification of 22q11.2 Deletion Syndrome via Newborn Screening for Severe Combined Immunodeficiency. Journal of Clinical Immunology 37(5): 476-485, July 2017.

Morsheimer, M, Brown-Whitehorn, TF, Heimall, J, Sullivan, KE: The Immune Deficiency of Chromosome 22q11.2 Deletion Syndrome. American Journal of Medical Genetics Part A June 2017.

Heimall Jennifer, Puck Jennifer, Buckley Rebecca, Fleisher Thomas A, Gennery Andrew R, Neven Benedicte, Slatter Mary, Haddad Elie, Notarangelo Luigi D, Baker K Scott, Dietz Andrew C, Duncan Christine, Pulsipher Michael A, Cowan Mort J: Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 23(3): 379-387, Mar 2017.

back to top
Last updated: 03/21/2018
The Trustees of the University of Pennsylvania